About this trial
The purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 18 - 60
For women, premenopausal status
Disqualifiers
Active cardiovascular or pulmonary disease (e.g. hypertension, coronary artery disease, cardiomyopathy, arrhythmia, valvular abnormalities, diabetes, peripheral vascular disease, tobacco use, chronic obstructive pulmonary disease, asthma, interstitial lung disease, restrictive lung disease, or pulmonary hypertension)
Use of cardiac- or pulmonary-related medications
Prior history of high altitude pulmonary edema or high altitude cerebral edema
Body mass index < 18.5 or > 30
Trial design
Crossover
Treatments tested in this trial
Ferrous sulfate 325mg
DrugParticipants will take one tab of ferrous sulfate 325 mg (equivalent to 65 mg elemental iron) daily for 30 days.
Treatment groups
Trial outcomes
Primary outcomes
Maximum workload
Workload in Watts at peak exercise on upright cycle ergometer
Maximal oxygen uptake
Maximal oxygen uptake at peak exercise (VO2max) in L/min
Secondary outcomes
Oxygen saturation at peak exercise
Peripheral oxygen saturation (SpO2)
Submaximal Stage 1 workload
Workload in Watts at 40% x hypoxic VO2max (obtained during baseline hypoxic exercise test)
Submaximal Stage 2 workload
Workload in Watts at 60% x hypoxic VO2max (obtained during baseline hypoxic exercise test)
Ventilatory threshold
Oxygen uptake (VO2 in L/min) at which slope of VCO2/VO2 relationship increases
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: